FPH announces executive management team changes
News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare expands executive management team, Paul Shearer to retire as
Senior Vice President - Sales & Marketing
Auckland, New Zealand, 20 December 2023 - Fisher & Paykel Healthcare Corporation Limited today
announced changes to its executive management team.
Paul Shearer, the company’s Senior Vice President - Sales & Marketing, plans to retire from full-time
duties on 31 March 2024 following more than three decades leading the company’s global sales and
marketing efforts. Justin Callahan, the company’s current President - North America & Europe, has
been appointed to the role of Vice President - Sales & Marketing with effect from 1 April 2024.
The company is also adding four new roles to the executive management team to ensure the business
is suitably structured for future growth.
The following changes are effective from 1 April 2024:
• Paul Shearer to retire as Senior Vice President - Sales & Marketing and transition to a new role
as an advisor to senior leadership in a part-time capacity.
• Justin Callahan appointed to the role of Vice President - Sales & Marketing.
• Andy Niccol appointed to the role of Chief Operating Officer and added to the executive
management team.
• Malena Ortiz added to the executive management team as General Director - Mexico
Operations.
• Desh Edirisuriya added to the executive management team as General Manager - New Zealand
Operations.
• Raelene Leonard added to the executive management team as General Counsel & Company
Secretary.
Retirement of Paul Shearer as Senior Vice President - Sales & Marketing and appointment of
Justin Callahan
Having been with the business for more than 33 years, Paul Shearer will step away from his full-time
role as Senior Vice President - Sales & Marketing at the end of the 2024 financial year. Paul will remain
with the company in a part-time advisory position for the next two years to provide strategic input to the
executive management team and coaching to sales leaders.
“Paul has played an incredibly significant role in the Fisher & Paykel Healthcare story,” said Lewis
Gradon, Managing Director & Chief Executive Officer for Fisher & Paykel Healthcare.
“Joining us in 1990, he established our sales operations in several major markets, including the United
States and the United Kingdom, and under his leadership we have built a direct sales presence in more
than 50 countries. I wish to thank Paul for his dedication and support, and I’m pleased that we will retain
his expertise in an advisory capacity going forward.”
Justin Callahan, currently President - North America & Europe, will take up the mantle as Vice
President - Sales & Marketing and join the executive management team. Beginning with the business in
Australia in 1988, Justin has led the company’s United States operations since 1996. He will continue to
be based in Irvine, California.
“Justin has had an impressive track record over more than 25 years and during his tenure has helped
deliver significant revenue and earnings growth in our North American business,” said Mr Gradon. “He
is well respected by our people, customers and members of the financial community and we believe he
will continue to add significant value to our global business in his new role.”
Additional changes to the executive management team
The company is also expanding the executive management team to lay the groundwork for its next
phase of sustainable, profitable growth.
“As our business continues to scale, ensuring we remain well-structured for future growth is essential,”
said Mr Gradon. “That rationale underpins each of the decisions we are announcing today.”
Andy Niccol, currently General Manager - Respiratory Humidification, will join the executive
management team in the newly created role of Chief Operating Officer. Andy has held a variety of
positions since first joining the company in 2001, spanning research and development, sales and global
original equipment manufacturer (OEM) partnership roles.
“We now have multiple manufacturing sites worldwide and a growing number of distribution locations,”
said Mr Gradon. “We want to create a sustainable business structure by establishing a global
operations function which includes manufacturing and supply chain. Andy is well-suited for the Chief
Operating Officer role, given his experience in leading large teams and complex projects as well as an
in-depth understanding of our culture, products and customers. We welcome the capability he will bring
to our executive management team.”
Joining Andy as new appointments to the executive management team are Malena Ortiz as General
Director - Mexico Operations, Desh Edirisuriya as General Manager - New Zealand Operations, and
Raelene Leonard as General Counsel & Company Secretary.
Malena joined Fisher & Paykel Healthcare more than 12 years ago when the company was in the early
stages of establishing its manufacturing presence in Mexico and has overseen the rapid expansion of
operations in Tijuana.
Desh has been with Fisher & Paykel Healthcare for more than 23 years and led the company’s
response to COVID-19. He has been an instrumental part of embedding a culture of continuous
improvement throughout the organisation.
Raelene has been with Fisher & Paykel Healthcare for eight years and possesses significant legal
experience gained across Asia Pacific and Europe prior to joining the company.
With effect from 1 April 2024, Paul Shearer will cease to be a Senior Manager of the company and both
Justin Callahan and Andy Niccol will become Senior Managers of the company, for the purposes of the
NZX Listing Rules.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems
for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The
company’s products are sold in over 120 countries worldwide. For more information about the company,
visit our website www.fphcare.com.
Media & Investor Contacts
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 (0) 21 713 911
Dan Adolph
Senior Communications & Investor Relations
Manager
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050
Authorised by Lewis Gradon, Managing Director & Chief Executive Officer for Fisher & Paykel
Healthcare.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FBU — Fletcher Building: Fletcher Building announces Executive appointment2024-02-26
“Fletcher Building Limited, Private Bag 92114, Auckland 1142, 810 Great South Road, Penrose, Auckland 1061, New Zealand Fletcher Building Announces Executive Appointment Auckland, 27 February 2024: Fletcher Building Ltd today announced the appointment of James Peters to…”
- FBU — Fletcher Building: Fletcher Building Executive team announcements2023-12-13
“Fletcher Building Limited, Private Bag 92114, Auckland 1142, 810 Great South Road, Penrose, Auckland 1061, New Zealand Fletcher Building Executive team announcements Auckland, 14 December 2023: Fletcher Building today announced the appointment of Gareth O’Reilly f…”
- FBU — Fletcher Building: Fletcher Building executive team announcement2023-11-23
“Fletcher Building Limited, Private Bag 92114, Auckland 1142, 810 Great South Road, Penrose, Auckland 1061, New Zealand Fletcher Building executive team announcement Auckland, 24 November 2023: Fletcher Building today announced that Bruce McEwen, Chief Executive of…”